| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Division of Pulmonary and Critical Care Medicine,* University of Michigan and the Department of Veterans Affairs Medical Center, Ann Arbor, Michigan; and the Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California
Granulocyte macrophage-colony stimulating factor (GM-CSF) plays an important role in pulmonary homeostasis, with effects on both alveolar macrophages and alveolar epithelial cells. We hypothesized that overexpression of GM-CSF in the lung would protect mice from hyperoxic lung injury by limiting alveolar epithelial cell injury. Wild-type C57BL/6 mice and mutant mice in which GM-CSF was overexpressed in the lung under control of the SP-C promoter (SP-C-GM mice) were placed in >95% oxygen. Within 6 days, 100% of the wild-type mice had died, while 70% of the SP-C-GM mice remained alive after 10 days in hyperoxia. Histological assessment of the lungs at day 4 revealed less disruption of the alveolar wall in SP-C-GM mice compared to wild-type mice. The concentration of albumin in bronchoalveolar lavage fluid after 4 days in hyperoxia was significantly lower in SP-C-GM mice than in wild-type mice, indicating preservation of alveolar epithelial barrier properties in the SP-C-GM mice. Alveolar fluid clearance was preserved in SP-C-GM mice in hyperoxia, but decreased significantly in hyperoxia-exposed wild-type mice. Staining of lung tissue for caspase 3 demonstrated increased apoptosis in alveolar wall cells in wild-type mice in hyperoxia compared to mice in room air. In contrast, SP-C-GM mice exposed to hyperoxia demonstrated only modest increase in alveolar wall apoptosis compared to room air. Systemic treatment with GM-CSF (9 µg/kg/day) during 4 days of hyperoxic exposure resulted in decreased apoptosis in the lungs compared to placebo. In studies using isolated murine type II alveolar epithelial cells, treatment with GM-CSF greatly reduced apoptosis in response to suspension culture. In conclusion, overexpression of GM-CSF enhances survival of mice in hyperoxia; this effect may be explained by preservation of alveolar epithelial barrier function and fluid clearance, at least in part because of reduction in hyperoxia-induced apoptosis of cells in the alveolar wall.
This article has been cited by other articles:
 |
|
 |
|
  L. Cakarova, L. M. Marsh, J. Wilhelm, K. Mayer, F. Grimminger, W. Seeger, J. Lohmeyer, and S. Herold Macrophage Tumor Necrosis Factor-{alpha} Induces Epithelial Expression of Granulocyte-Macrophage Colony-stimulating Factor: Impact on Alveolar Epithelial Repair Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 521 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kolliputi and A. B. Waxman IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L6 - L16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Beck, A. M. Preston, S. E. Wilcoxen, S. B. Morris, A. Sturrock, and R. Paine III Critical Roles of Inflammation and Apoptosis in Improved Survival in a Model of Hyperoxia-Induced Acute Lung Injury in Pneumocystis murina-Infected Mice Infect. Immun., March 1, 2009; 77(3): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Looney, C T Esmon, and M A Matthay Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury Thorax, February 1, 2009; 64(2): 114 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Murray, D. A. Knight, L. McAlonan, R. Argentieri, A. Joshi, F. Shaheen, M. Cunningham, L. Alexopolou, R. A. Flavell, R. T. Sarisky, et al. Deleterious Role of TLR3 during Hyperoxia-induced Acute Lung Injury Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1227 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Mendez, S. B. Morris, S. Wilcoxen, M. Du, Y. K. Monroy, H. Remmer, H. Murphy, P. J. Christensen, and R. Paine III Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L807 - L814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bhandari, R. Choo-Wing, R. J. Homer, and J. A. Elias Increased Hyperoxia-Induced Mortality and Acute Lung Injury in IL-13 Null Mice J. Immunol., April 15, 2007; 178(8): 4993 - 5000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Calfee and M. A. Matthay Nonventilatory Treatments for Acute Lung Injury and ARDS Chest, March 1, 2007; 131(3): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. O. Baleeiro, P. J. Christensen, S. B. Morris, M. P. Mendez, S. E. Wilcoxen, and R. Paine III GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1246 - L1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Xu, J. R. Guthrie, S. Mabry, T. M. Sack, and W. E. Truog Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L966 - L975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Mendez, S. B. Morris, S. Wilcoxen, E. Greeson, B. Moore, and R. Paine III Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L962 - L970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Matthay and E. Abraham beta-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 254 - 255. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Looney, C. Sartori, S. Chakraborty, P. F. James, J. B. Lingrel, and M. A. Matthay Decreased expression of both the {alpha}1- and {alpha}2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L104 - L110. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
